Skip to main content
Equibles

Steven D. Harr, M.D.

Board Member

Sana Biotechnology, Inc. (SANA)

CFO

Sana Biotechnology, Inc. (SANA)

Equibles does not estimate personal net worth.

Get an email with a short summary when Sana Biotechnology, Inc. publishes a filing, an earnings call transcript or a press release.

Get SANA alerts

About Steven D. Harr, M.D.

Steven D. Harr, M.D. is recorded as Board Member at Sana Biotechnology, Inc. (SANA) since April 22, 2026 and CFO at Sana Biotechnology, Inc. (SANA) since October 4, 2024. Sana Biotechnology, Inc. reported in an 8-K filed April 24, 2026 that Steven D. Harr, M.D. was appointed Class III director, effective April 22, 2026. Sana Biotechnology, Inc. reported in an 8-K filed April 24, 2026 that Steven D. Harr, M.D. resigned as Class I director, effective April 22, 2026. Sana Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sana Biotechnology, Inc. includes Brian Piper (CFO), Steven D. Harr (CFO), Susan Wyrick (CFO) and 4 others.

“on April 22, 2026, contingent upon and effective as of immediately prior to his re-appointment to the Board as a Class III director, Steven D. Harr, M.D., tendered his resignation from his position as a Class I director to the Board, and on the same date, the Board accepted such resignation and immediately re-appointed him as a Class III director.”
Sana Biotechnology, Inc. Form 8-K, filed April 24, 2026 · Read the filing
“on April 22, 2026, contingent upon and effective as of immediately prior to his re-appointment to the Board as a Class III director, Steven D. Harr, M.D., tendered his resignation from his position as a Class I director to the Board, and on the same date, the Board accepted such resignation and immediately re-appointed him as a Class III director.”
Sana Biotechnology, Inc. Form 8-K, filed April 24, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Sana Biotechnology, Inc.

Recent activity